NDC 61919-835
Oxycodone/APAP
Oxycodone/apap
Oxycodone/APAP is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Direct_rx. The primary component is Oxycodone Hydrochloride; Acetaminophen.
| Product ID | 61919-835_8c3b715b-4553-fb38-e053-2995a90a3d42 |
| NDC | 61919-835 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Oxycodone/APAP |
| Generic Name | Oxycodone/apap |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-06-26 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA207419 |
| Labeler Name | Direct_Rx |
| Substance Name | OXYCODONE HYDROCHLORIDE; ACETAMINOPHEN |
| Active Ingredient Strength | 8 mg/1; mg/1 |
| Pharm Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
| DEA Schedule | CII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |